Physicians' Academy for Cardiovascular Education

T2DM & cardiovascular risk: Determinants of Risk and Implications for Choice of Therapy

Lecture - May 6, 2017 - Beijing, China - Prof. Sanjay Rajagopalan, MD Cleveland, OH, USA - CDMC 2017

This lecture was part of a Cardio Diabetes Master Class 'CVM Summit 2017, held on May 5, 2017 in Beijing, China

Educational information

The educational objectives of the program were:


Prof. Sanjay Rajagopalan, MD - is Chief, Cardiovascular Medicine - Herman Hellerstein Chair of Cardiovascular Research. Director, Cardiovascular Research Institute. Professor of Medicine, Case Western Reserve School of Medicine - Cleveland, OH


The master class is supported by an unrestricted educational grant provided by Takeda Pharmaceuticals Inc

Download lecture as PDF

View slides

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: